Firms

NewVale Capital

Boulder, Colorado, United States

NewVale Capital is the US life-sciences growth-equity investment manager legally NewVale Capital LLC, SEC exempt reporting adviser CRD328660/file802-130072. Its own regulatory disclosures state reliance on the venture-capital-fund adviser exemption; it is not represented as a fully SEC-registered adviser. Its current own LinkedIn profile dates establishment to2021, while its original2024 fund announcement says2022; the discrepancy is preserved, it backs proven revenue-generating services, software and enabling technologies across the pharmaceutical value chain, including manufacturing, clinical research and supply-chain infrastructure. Founder Todd Holmes leads a current published team of thirteen professionals. Three operating partners are expressly not employees of NewVale or its affiliates, and those external affiliations are qualified. The current portfolio includes Aizon’s pharmaceutical manufacturing AI, Beaconcure’s clinical-trial data validation software, Argonaut manufacturing services, CAI validation services and Noxilizer sterilisation technology. NewVale led Aizon’s USD20M SeriesC announced February8,2024; the literal subscribing fund vehicle and individual ticket are undisclosed. Its May13,2024 original announcement explicitly confirms the final USD167M close of its inaugural fund. The release’s footnote about co-investment special-purpose vehicles attaches instead to the separate nearly USD200M total assets-under-management figure, so combined AUM is not assigned as FundI corpus. The Delaware FundI’s actual USD167M corpus is distinguished from separate SEC-disclosed SPVs, whose unverified closed sizes remain omitted. Actual legal cash-closing days remain unpublished. Existing company board roles and shared professional biographies/portraits are preserved.

Founded: 2021
Type: Venture capital

Funds3

NEWVALE CAPITAL FUND I LP—$167M
ExactDelaware NewValeCapitalFundILP primarySECADV328660 identification8058602424529, GPNewValeCapitalWarehouseGPLLC. OriginalMay13,2024managerrelease explicitly confirms FINALinauguralfundcloseUSD167M capitalcommitments. Its co-investmentSPVfootnote attaches separateNEARLY200MtotalAUMfigure, NOT167Mfundsize; initialoverbroadscope corrected. Exactlegalcashclosingdayunpublished/dateNULL, sourceannouncementMay13. No200MAUMcashclose orSPVdoublecount.
NewVale Capital Holdings 3 LLC——
ExactDelawarepooledinvestmentSPV incorporated2024, SECFormD CIK2044744 signedNovember22,2024 byToddHolmes. Originalreportedtotal1M TARGET/zeroSOLD/zerooutsideinvestors; amountNULL, notcompleted1Mfundclose orcompanycash. SeparatemanagerLLCofficerconfirmed.
NEWVALE CAPITAL SPV MDH LLC——
ExactSECFormD issuerCIK1966030, filingFebruary21,2023, DelawareSPV c/oNewValeCapitalLLC Boulder. Originalfundsize/fullclosingday unverified andNULL; no equivalencetoFundI or guessedportfolio-companycash.